Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

{{article.zuoZheCn}}

PDF(216 KB)
PDF(216 KB)
Frontiers of Medicine ›› 2019, Vol. 13 ›› Issue (3) : 365-377. DOI: 10.1007/s11684-018-0641-0

  • {{article.zuoZheCn}}
作者信息 +

Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

  • {{article.zuoZheEn}}
Author information +
History +

本文亮点

{{article.highlightCn}}

Highlight

{{article.highlightEn}}

摘要

{{article.abstractCn}}

Abstract

{{article.abstractEn}}

作者总结

{{article.authorSummayCn}}

Author summay

{{article.authorSummayEn}}

关键词

Keywords

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.titleCn}}. {{journal.nameCn}}. 2019, 13(3): 365-377 https://doi.org/10.1007/s11684-018-0641-0

参考文献

参考文献

{{article.reference}}

版权

{{article.copyright.year}} {{article.copyright.holder}}
PDF(216 KB)

Accesses

Citation

Detail

段落导航
相关文章

/